Wang Yanni, Huang Xia, Chen Fuheng, Gao Yuanyuan, Cui Xiangrong, Yan Qin, Jing Xuan
Fifth Clinical Medical College of Shanxi Medical University, Taiyuan 030012, China.
Clinical Laboratory, Shanxi Provincial People's Hospital, Fifth Hospital of Shanxi Medical University, Taiyuan 030012, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Dec 20;44(12):2388-2395. doi: 10.12122/j.issn.1673-4254.2024.12.15.
To investigate the correlation of serum levels of bridging integrating factor 1 (BIN1) with acute myocardial infarction (AMI) and Killip class of the patients.
We retrospectively collected the data from 94 patients with AMI and 30 healthy individuals for analysis of the correlations of serum BIN1 levels with Killip class, TIMI scores, and neutrophil-to-lymphocyte ratio (NLR). We also assessed the diagnostic value of BIN1 combined with NLR for AMI.
Serum BIN1 levels were significantly lower in AMI patients than in the healthy individuals (=0.032). The AMI patients with Killip class I had significantly lower serum BIN1 levels than the healthy individuals (=0.008). Serum BIN1 level was an independent predictor of AMI with a predictive value of 0.630 (95% : 0.513-0.748) at the optimal cutoff level of 0.341 ng/mL, a specificity of 50%, and a sensitivity of 78.5%. Serum BIN1 level was also an independent predictor for Killip class I group in the AMI patients with a predictive value of 0.672 (95% : 0.548-0.797) at the optimal cutoff level of 0.287 ng/mL, a specificity of 74.1%, and a sensitivity of 60%. For AMI diagnosis, the combination of NLR and serum BIN1 level had a predictive value of 0.811 (95% : 0.727-0.895) at the optimal cutoff level of 0.548 ng/mL, with a specificity of 92.6% and a sensitivity of 62.2%. There was a positive correlation between serum BIN1 level and TIMI score in AMI patients (=0.186, =0.003).
BIN1 is correlated with AMI and can be helpful for predicting short-term prognosis of the patients, and BIN1 combined with NLR has a high diagnostic value for AMI.
探讨桥连整合因子1(BIN1)血清水平与急性心肌梗死(AMI)及患者Killip分级的相关性。
我们回顾性收集了94例AMI患者和30例健康个体的数据,以分析血清BIN1水平与Killip分级、心肌梗死溶栓治疗(TIMI)评分及中性粒细胞与淋巴细胞比值(NLR)的相关性。我们还评估了BIN1联合NLR对AMI的诊断价值。
AMI患者血清BIN1水平显著低于健康个体(P = 0.032)。Killip I级的AMI患者血清BIN1水平显著低于健康个体(P = 0.008)。血清BIN1水平是AMI的独立预测指标,在最佳截断水平为0.341 ng/mL时,预测值为0.630(95%置信区间:0.513 - 0.748),特异性为50%,敏感性为78.5%。血清BIN1水平也是AMI患者中Killip I级组的独立预测指标,在最佳截断水平为0.287 ng/mL时,预测值为0.672(95%置信区间:0.548 - 0.797),特异性为74.1%,敏感性为60%。对于AMI诊断,在最佳截断水平为0.548 ng/mL时,NLR与血清BIN1水平联合的预测值为0.811(95%置信区间:0.727 - 0.895),特异性为92.6%,敏感性为62.2%。AMI患者血清BIN1水平与TIMI评分呈正相关(P = 0.186,P = 0.003)。
BIN1与AMI相关,有助于预测患者的短期预后,且BIN1联合NLR对AMI具有较高的诊断价值。